Clinical trial
Renoprotection in Early Diabetic Nephropathy in Pima Indians
NCT00340678 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00340678 |
|---|---|
| Title | Renoprotection in Early Diabetic Nephropathy in Pima Indians |
| Official title | Renoprotection in Early Diabetic Nephropathy in Pima Indians |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | Losartan, Placebo |
| Enrollment | 170 |
| Start date | Aug 1, 1995 |
| Primary completion | May 1, 2012 |
| Completion | Mar 1, 2014 |
| First posted | Jun 21, 2006 |
| Last update posted | Mar 25, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: